CN102258609A - Sanhuang antipruritic liniment and its preparation method - Google Patents
Sanhuang antipruritic liniment and its preparation method Download PDFInfo
- Publication number
- CN102258609A CN102258609A CN2011102022069A CN201110202206A CN102258609A CN 102258609 A CN102258609 A CN 102258609A CN 2011102022069 A CN2011102022069 A CN 2011102022069A CN 201110202206 A CN201110202206 A CN 201110202206A CN 102258609 A CN102258609 A CN 102258609A
- Authority
- CN
- China
- Prior art keywords
- radix
- sanhuang
- weight portion
- liniment
- antipruritic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
The invention relates to an external-use liniment of a pharmaceutical composition and a preparation method thereof, and specifically relates to a Sanhuang antipruritic liniment and its preparation method. Calculated by 1000 total weight account, the liniment provided by the invention comprises the following raw medicines of: by weight, 20-30 parts of sophora flavescens, 20-30 parts of rheum officinale, 20-30 parts of Baikal Skullcap Root, and 20-30 parts of Cortex Phellodendri. The preparation method provided by the invention comprises the following steps of: mixing the above raw medicines according to the above weight portions, crushing to fine powders, sieving through a sieve and mixing uniformly; adding 3-10 parts of fully swelled carboxymethylcellulose sodium, adding 5-15 parts of melted phenol, uniformly stirring, and adjusting the total amount to 1000 weight portions by adding water. The Sanhuang antipruritic liniment provided by the invention has functions of clearing heat, detoxifying, inducing astringency and relieving itching, can be used to treat skin diseases such as skin redness, hot itching and exudation in the acute phase due to the toxic heat of the skin, has not only a heat-clearing effect but also a convergence effect, and is suitable for various skin injuries with a few exudation in the acute phase; in addition, the Sanhuang antipruritic liniment is a pure traditional Chinese medicinal preparation, is safe to use with no stimulation, can be used for a long time, and has a low price.
Description
Technical field
The present invention relates to externally-applied liniment of a kind of pharmaceutical composition and preparation method thereof, be specifically related to a kind of SANHUANG antipruritic application agent and preparation method thereof.
Background technology
At present clinically for acne, rosacea, furunculosis, eczema, dermatitis (acute stage, have and slightly do not ooze out the person), herpes zoster cases such as (vesicle person appear in acute stage), the common following Drug therapy that adopts, for example Chang Yong treatment acne medicine for external use has: 1. tretinoin: as tretinoin emulsifiable paste (15～20 yuan), Avita Gel (35 yuan), isotretinoin gel (more than 50 yuan) etc., but can occur slight irritant reaction (as local flushing, desquamation or burn feeling) after the medication.2. antibiotics:, be suitable for the erythra of infection as 1%～2% erythromycin ointment (1～2 yuan), lincomycin VB6 ointment (about 30 yuan).This two classes medicine effect is limited, and part patient has sense of discomfort.Treatment rosacea medicine for external use commonly used has more than the 0.75% Metrogel 20g(20 unit), antibacterial action is arranged, short-term is used effectively; Compound sulfur lotion or 5% sulphur ointment (5～10 yuan) have certain curative effect, but skin irritation reaction and pungent taste are often arranged.Treatment furunculosis medicine for external use commonly used has: about mupirocin ointment 5g(15 unit) effect is limited.Treatment eczema commonly used, the medicine for external use of dermatitis have external glucocorticoid paste or 25%～40% zinc oxid oil or paste (generally being hospital's self-control); Mostly be ointment greatly in the product of listing, life-time service hormone ointment easily produces various untoward reaction, and has been unsuitable for the person of oozing out.The medicine for external use of treatment herpes zoster (vesicle person appears in acute stage) commonly used has: use Calamine Lotion 100ml, 3% acyclovir ointment 10g, 1% Denavir 10g when bleb liquid is broken; Behind the herpes ulceration with 3% boric acid solution 200ml, mupirocin ointment 5g.
Summary of the invention
The objective of the invention is provides a kind of SANHUANG antipruritic application agent and preparation method thereof according to above-mentioned the deficiencies in the prior art part, and this liniment is a pure Chinese medicinal preparation, is used for the disease that the skin pyretic toxicity is had an itch, and effect is very obvious.
The object of the invention realizes being finished by following technical scheme:
A kind of SANHUANG antipruritic application agent is characterized in that described liniment calculates with 1000 total weight parts, and its crude drug is formed and the shared weight portion of consumption is respectively: Radix Sophorae Flavescentis 20-30, Radix Et Rhizoma Rhei 20-30, Radix Scutellariae 20-30, Cortex Phellodendri 20-30.
The crude drug of described liniment is formed and the shared weight portion of consumption is respectively: Radix Sophorae Flavescentis 20-30, Radix Et Rhizoma Rhei 20-30, Radix Scutellariae 20-30, Cortex Phellodendri 20-30, Herba Hedyotidis Diffusae 20-30, Herba Taraxaci 20-30.
The crude drug of described liniment is formed and the shared weight portion of consumption is respectively: Radix Sophorae Flavescentis 20-30, Radix Et Rhizoma Rhei 20-30, Radix Scutellariae 20-30, Cortex Phellodendri 20-30, Radix Rehmanniae 20-30, Cortex Mori 15-30.
The crude drug of described liniment is formed and the shared weight portion of consumption is respectively: Radix Sophorae Flavescentis 20-30, Radix Et Rhizoma Rhei 20-30, Radix Scutellariae 20-30, Cortex Phellodendri 20-30, Flos Lonicerae 15-20, Flos Chrysanthemi Indici 10-20.
The crude drug of described liniment is formed and the shared weight portion of consumption is respectively: Radix Sophorae Flavescentis 20-30, Radix Et Rhizoma Rhei 20-30, Radix Scutellariae 20-30, Cortex Phellodendri 20-30, Rhizoma Smilacis Glabrae 20-30.
The crude drug of described liniment is formed and the shared weight portion of consumption is respectively: Radix Sophorae Flavescentis 20-30, Radix Et Rhizoma Rhei 20-30, Radix Scutellariae 20-30, Cortex Phellodendri 20-30, Radix Gentianae 10-15, Gardenia 20-30.
A kind of preparation method of SANHUANG antipruritic application agent is characterized in that the above-mentioned raw materials medicine is formed, and according to above-mentioned weight portion, mixes, is ground into fine powder, crosses mesh sieve, mixing afterwards; Add the sodium carboxymethyl cellulose 3-10 weight portion of complete swelling, add the phenol 5-15 weight portion that has melted again, stir evenly, add water and adjust total amount to 1000 weight portion, promptly.
Advantage of the present invention is, heat-clearing and toxic substances removing, relieving iching by astringing are used for acute stage red swelling of the skin, pruritus due to heat that skin causes because of hyperactivity of toxic heat, dermatosis such as ooze out, and existing heat clearing away effect has astriction again, is suitable for acute stage with the various skin lesion that ooze out on a small quantity; Pure Chinese medicinal preparation, safe in utilization, non-stimulated, but life-time service; Price is lower.
The specific embodiment
By the following examples feature of the present invention and other correlated characteristic are described in further detail, so that technical staff's of the same trade understanding:
Embodiment one:
Crude drug is formed and consumption is: Radix Sophorae Flavescentis 25g, Radix Et Rhizoma Rhei 25g, Radix Scutellariae 25g, Cortex Phellodendri 25g.
Above-mentioned raw materials is formed according to above-mentioned weight portion, mixed, be ground into fine powder, cross 80 mesh sieves, mixing afterwards; Add the sodium carboxymethyl cellulose 5g of complete swelling, add the phenol 10g that has melted again, stir evenly, add water and adjust total amount to 1000ml.
The using method of the described liniment of present embodiment is as follows:
With adopt above-mentioned preparation method system liniment by the 100 ml/ bottle branches bottle of packing into.Partial smearing, 1 time every night, with before shaking up.2 weeks were 1 course of treatment.
Embodiment two: present embodiment and the difference of embodiment one be crude drug form different, present embodiment at the patient that the acne disease is arranged.
Crude drug is formed: Radix Sophorae Flavescentis 25g, Radix Et Rhizoma Rhei 25g, Radix Scutellariae 25g, Cortex Phellodendri 25g, Herba Hedyotidis Diffusae 30, Herba Taraxaci 30.2 weeks were 1 course of treatment.
The state of an illness symptom of acne: whelk, blackhead, serious symptom have pustule, tuberosity, cyst.
Below be that present embodiment and contrast groups are applied to clinical report: every group of patient 20 people.
| Group | Treatment time (week) | Clinical cure (example) | Take a turn for the better (example) | (example) do not heal |
| Adopt the tretinoin group | 2 | 1 | 3 | 16 |
| Adopt the tretinoin group | 4 | 4 | 4 | 12 |
| One group of embodiment | 2 | 0 | 6 | 14 |
| One group of embodiment | 4 | 8 | 8 | 4 |
| Two groups of embodiment | 2 | 4 | 6 | 10 |
| Two groups of embodiment | 4 | 12 | 4 | 4 |
With reference to " disease of tcm diagnosis criterion of therapeutical effect ", above-mentioned acne criterion of therapeutical effect is as follows:
Clinical cure: skin lesion is disappeared, and subjective symptoms disappears;
Take a turn for the better: subjective symptoms obviously alleviates, and skin lesion disappears more than 30%;
Do not heal: the equal no change of skin lesion and symptom or the less than 30% that disappears.
Can see by above-mentioned routine table, compare with existing medicine, embodiment one all is better than the contrast groups medicine with the effect of embodiment two, and the effect of embodiment two is better than the effect of embodiment one, price has no side effect far below last two class medicines, and 100% patient to react the foregoing description medicine clearing heat and anti-inflammatory functions strong, can take effect rapidly, not have uncomfortable sensation.
Embodiment three: present embodiment and the difference of embodiment one be crude drug form different, present embodiment at the patient that the rosacea disease is arranged.
Crude drug is formed: Radix Sophorae Flavescentis 25g, Radix Et Rhizoma Rhei 25g, Radix Scutellariae 25g, Cortex Phellodendri 25g, the Radix Rehmanniae 30, Cortex Mori 30.2 weeks were 1 course of treatment.
Rosacea state of an illness symptom: the nose flushing, obvious when excited, pimple, pustule, telangiectasis is obvious, and pachyderma forms pachydermatosis at last.
Below be that present embodiment and contrast groups are applied to clinical report: every group of patient 20 people.
| Group | Treatment time (week) | Clinical cure (example) | Take a turn for the better (example) | (example) do not heal |
| Compound sulfur lotion or 5% sulphur ointment | 2 | 0 | 2 | 18 |
| Compound sulfur lotion or 5% sulphur ointment | 4 | 2 | 6 | 12 |
| One group of embodiment | 2 | 0 | 8 | 12 |
| One group of embodiment | 4 | 4 | 12 | 4 |
| Three groups of embodiment | 2 | 4 | 10 | 6 |
| Three groups of embodiment | 4 | 8 | 8 | 4 |
With reference to " disease of tcm diagnosis criterion of therapeutical effect ", above-mentioned acne rosacea criterion of therapeutical effect is as follows:
Clinical cure: skin lesion disappears.
Take a turn for the better: the part skin lesion alleviates, or disappears more than 30%.
Do not heal: the skin lesion no change or the less than 30% that disappears.
Can see by above-mentioned routine table, compare with existing medicine, embodiment one all is better than the contrast groups medicine with the effect of embodiment three, and the effect of embodiment three is better than the effect of embodiment one, and it is strong that 100% patient reacts the heat clearing away of the foregoing description medicine, removing heat from blood, antiinflammation, instant effect, non-stimulated sensation, but life-time service.
Embodiment four: present embodiment and the difference of embodiment one be crude drug form different, present embodiment at the patient that the furunculosis disease is arranged.
Crude drug is formed: Radix Sophorae Flavescentis 25g, Radix Et Rhizoma Rhei 25g, Radix Scutellariae 25g, Cortex Phellodendri 25g, Flos Chrysanthemi Indici 30, Flos Lonicerae 20.1 week was 1 course of treatment.
Furunculosis state of an illness symptom: exceed the cerise hair follicle pimple of skin, cumulative big, pain became pus in 2-3 days, promptly healed after bursting.Whole body distributes everywhere, or shows effect repeatedly at certain position.
Below be that present embodiment and contrast groups are applied to clinical report: every group of patient 20 people.
| Group | Treatment time (week) | Clinical cure (example) | Take a turn for the better (example) | (example) do not heal |
| Mupirocin ointment | 0.5 | 2 | 8 | 10 |
| Mupirocin ointment | 1 | 4 | 6 | 10 |
| One group of embodiment | 0.5 | 2 | 10 | 8 |
| One group of embodiment | 1 | 8 | 8 | 4 |
| Four groups of embodiment | 0.5 | 4 | 6 | 10 |
| Four groups of embodiment | 1 | 4 | 14 | 2 |
With reference to " disease of tcm diagnosis criterion of therapeutical effect ", above-mentioned furunculosis criterion of therapeutical effect is as follows:
Clinical cure: furuncle and phyma dissipates or the back healing of bursting, and General Symptoms disappears.
Take a turn for the better: send out the furuncle and phyma number again and reduce sx.
Do not heal: this heals that rises furuncle and phyma, can not control.
Can see by above-mentioned routine table, compare with existing medicine, embodiment one all is better than the Comparative Examples medicine with the effect of embodiment four, and the effect of embodiment four is better than the effect of embodiment one, the foregoing description medicine has antipyretic and antidote functions preferably, furunculosis for outbreak repeatedly has curative effect preferably, and can reduce recurrence.
Embodiment five: present embodiment and the difference of embodiment one be crude drug form different, present embodiment at the patient that eczema, dermatitis (acute stage has and slightly do not ooze out the person) disease are arranged.
Crude drug is formed: Radix Sophorae Flavescentis 25g, Radix Et Rhizoma Rhei 25g, Radix Scutellariae 25g, Cortex Phellodendri 25g, Rhizoma Smilacis Glabrae 30.2 weeks were 1 course of treatment.
The state of an illness symptom of eczema, dermatitis (acute stage has and slightly do not ooze out the person): acute eczema has erythema, pimple, vesicle, oozes out, and is symmetrically distributed, and acutely scratches where it itches.
Below be that present embodiment and contrast groups are applied to clinical report: every group of patient 20 people.
| Group | Treatment time (week) | Clinical cure (example) | Take a turn for the better (example) | (example) do not heal |
| External glucocorticoid paste | 2 | 0 | 8 | 12 |
| External glucocorticoid paste | 4 | 2 | 10 | 8 |
| One group of embodiment | 2 | 0 | 10 | 10 |
| One group of embodiment | 4 | 4 | 10 | 6 |
| Five groups of embodiment | 2 | 2 | 12 | 6 |
| Five groups of embodiment | 4 | 8 | 10 | 2 |
With reference to " disease of tcm diagnosis criterion of therapeutical effect ", above-mentioned eczema criterion of therapeutical effect is as follows:
Clinical cure: skin lesion disappears.
Take a turn for the better: skin lesion disappears more than 30%.
Do not heal: the skin lesion less than 30% that disappears.
Can see by above-mentioned routine table, compare with existing medicine, embodiment one all is better than the Comparative Examples medicine with the effect of embodiment five, and the effect of embodiment five is better than the effect of embodiment one, is applicable to that acute stage eczema, dermatitis have slightly not ooze out the person, heat clearing away, antiinflammatory and astriction are obvious, owing to be the Chinese medicine preparation of no hormone, can use safely in tender and lovely skin places such as faces, but and life-time service, and 100% patient reacts instant effect, does not have uncomfortable sensation.
Embodiment six: present embodiment and the difference of embodiment one be crude drug form different, present embodiment at the patient that herpes zoster (vesicle person appears in acute stage) disease is arranged.
Crude drug is formed: Radix Sophorae Flavescentis 25g, Radix Et Rhizoma Rhei 25g, Radix Scutellariae 25g, Cortex Phellodendri 25g, Radix Gentianae 15, Gardenia 30.1 week was 1 course of treatment.
Herpes zoster (vesicle person appears in acute stage) state of an illness symptom: one-sided skin has the vesicle of Semen phaseoli radiati size, is zonal distribution, sharp ache.
Below be that present embodiment and contrast groups are applied to clinical report: every group of patient 20 people.
| Group | Treatment time (week) | Clinical cure (example) | Take a turn for the better (example) | (example) do not heal |
| With Calamine Lotion, acyclovir ointment, Denavir | 1 | 0 | 4 | 16 |
| With Calamine Lotion, acyclovir ointment, Denavir | 2 | 0 | 8 | 12 |
| Boric acid solution, mupirocin ointment | 1 | 0 | 4 | 16 |
| Boric acid solution, mupirocin ointment | 2 | 0 | 6 | 14 |
| One group of embodiment | 1 | 0 | 8 | 12 |
| One group of embodiment | 2 | 3 | 11 | 6 |
| Six groups of embodiment | 1 | 6 | 8 | 6 |
| Six groups of embodiment | 2 | 10 | 6 | 4 |
With reference to " disease of tcm diagnosis criterion of therapeutical effect ", above-mentioned herpes zoster criterion of therapeutical effect is as follows:
Clinical cure: deflorescence, clinical sign disappears, no pain sequela.
Take a turn for the better: deflorescence is about 30%, and pain obviously alleviates.
Do not heal: deflorescence less than 30% still has pain.
Can see by above-mentioned routine table, compare with existing medicine, embodiment one all is better than the Comparative Examples medicine with the effect of embodiment six, and the effect of embodiment six is better than the effect of embodiment one, and 100% patient reacts the foregoing description medicine instant effect, does not have uncomfortable sensation, the existing heat clearing away effect of this medicine liniment, astriction is arranged again, be suitable for the herpes zoster acute stage various skin lesion when vesicle occurring.
The sodium carboxymethyl cellulose that those skilled in the art obviously know in the foregoing description Chinese medicine component is as thickening agent, and phenol is as antiseptic, and how much obviously can increasing and decreasing in right amount according to concrete needs of its addition do not repeat them here.
Claims (7)
1. a SANHUANG antipruritic application agent is characterized in that described liniment calculates with 1000 total weight parts, and its crude drug is formed and the shared weight portion of consumption is respectively: Radix Sophorae Flavescentis 20-30, Radix Et Rhizoma Rhei 20-30, Radix Scutellariae 20-30, Cortex Phellodendri 20-30.
2. a kind of SANHUANG antipruritic application agent according to claim 1 is characterized in that the crude drug composition and the shared weight portion of consumption of described liniment is respectively: Radix Sophorae Flavescentis 20-30, Radix Et Rhizoma Rhei 20-30, Radix Scutellariae 20-30, Cortex Phellodendri 20-30, Herba Hedyotidis Diffusae 20-30, Herba Taraxaci 20-30.
3. a kind of SANHUANG antipruritic application agent according to claim 1 is characterized in that the crude drug composition and the shared weight portion of consumption of described liniment is respectively: Radix Sophorae Flavescentis 20-30, Radix Et Rhizoma Rhei 20-30, Radix Scutellariae 20-30, Cortex Phellodendri 20-30, Radix Rehmanniae 20-30, Cortex Mori 15-30.
4. a kind of SANHUANG antipruritic application agent according to claim 1 is characterized in that the crude drug composition and the shared weight portion of consumption of described liniment is respectively: Radix Sophorae Flavescentis 20-30, Radix Et Rhizoma Rhei 20-30, Radix Scutellariae 20-30, Cortex Phellodendri 20-30, Flos Lonicerae 15-20, Flos Chrysanthemi Indici 10-20.
5. a kind of SANHUANG antipruritic application agent according to claim 1 is characterized in that the crude drug composition and the shared weight portion of consumption of described liniment is respectively: Radix Sophorae Flavescentis 20-30, Radix Et Rhizoma Rhei 20-30, Radix Scutellariae 20-30, Cortex Phellodendri 20-30, Rhizoma Smilacis Glabrae 20-30.
6. a kind of SANHUANG antipruritic application agent according to claim 1 is characterized in that the crude drug composition and the shared weight portion of consumption of described liniment is respectively: Radix Sophorae Flavescentis 20-30, Radix Et Rhizoma Rhei 20-30, Radix Scutellariae 20-30, Cortex Phellodendri 20-30, Radix Gentianae 10-15, Gardenia 20-30.
7. the preparation method of a SANHUANG antipruritic application agent is characterized in that described method is that the above-mentioned raw materials medicine is formed, and according to above-mentioned weight portion, mixes, is ground into fine powder, crosses mesh sieve, mixing afterwards; Add the sodium carboxymethyl cellulose 3-10 weight portion of complete swelling, add the phenol 5-15 weight portion that has melted again, stir evenly, add water and adjust total amount to 1000 weight portion, promptly.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110202206 CN102258609B (en) | 2011-07-19 | 2011-07-19 | Sanhuang antipruritic liniment and its preparation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110202206 CN102258609B (en) | 2011-07-19 | 2011-07-19 | Sanhuang antipruritic liniment and its preparation method |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210301307.6A Division CN102793785B (en) | 2011-07-19 | 2011-07-19 | Chinese rhubarb-baical skullcap root-amur corktree bark itching-relieving liniment and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102258609A true CN102258609A (en) | 2011-11-30 |
| CN102258609B CN102258609B (en) | 2013-04-10 |
Family
ID=45005575
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201110202206 Expired - Fee Related CN102258609B (en) | 2011-07-19 | 2011-07-19 | Sanhuang antipruritic liniment and its preparation method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102258609B (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102784223A (en) * | 2012-07-23 | 2012-11-21 | 杭州市中医院 | Application of three-medicine ointment in preparation of drugs used for preventing and curing phlebitis |
| CN102908411A (en) * | 2012-11-21 | 2013-02-06 | 安文娟 | Ointment for treating acne |
| CN104523529A (en) * | 2015-01-08 | 2015-04-22 | 江苏省中医院 | Traditional Chinese medicine wet tissue for skin decontamination, preparation method thereof and traditional Chinese medicine composition |
| CN105055869A (en) * | 2015-07-21 | 2015-11-18 | 徐以燕 | Traditional Chinese medicinal external liniment and nursing method for treating rosacea with syndrome of heat-toxin exuberance |
| CN108378991A (en) * | 2018-05-07 | 2018-08-10 | 浙江卫星新材料科技有限公司 | Paper diaper containing kuh-seng |
| CN109646612A (en) * | 2019-02-28 | 2019-04-19 | 嘉兴市中医医院 | A kind of removing dampness to stop itchin mixture and preparation method thereof |
| CN110755508A (en) * | 2019-12-25 | 2020-02-07 | 长春雷允上药业有限公司 | Traditional Chinese medicine composition for relieving swelling and itching and preparation method thereof |
| CN114452318A (en) * | 2022-02-22 | 2022-05-10 | 威高(北京)医疗科技有限公司 | Anti-inflammatory traditional Chinese medicine composition for sanitary products and preparation method and application thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1291473A (en) * | 2000-07-25 | 2001-04-18 | 张俊峰 | Series cosmetics for treating acne on face |
| CN1548034A (en) * | 2003-05-21 | 2004-11-24 | 哈药集团三精制药有限公司 | Sahuanglian skin care washing article |
| CN1895428A (en) * | 2006-06-10 | 2007-01-17 | 江国潮 | Embrocation medicine for treating acute scrotum eczema and its preparation |
| CN101732462A (en) * | 2009-11-11 | 2010-06-16 | 宋爱民 | Chinese medicinal preparation for treating herpes zoster |
-
2011
- 2011-07-19 CN CN 201110202206 patent/CN102258609B/en not_active Expired - Fee Related
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1291473A (en) * | 2000-07-25 | 2001-04-18 | 张俊峰 | Series cosmetics for treating acne on face |
| CN1548034A (en) * | 2003-05-21 | 2004-11-24 | 哈药集团三精制药有限公司 | Sahuanglian skin care washing article |
| CN1895428A (en) * | 2006-06-10 | 2007-01-17 | 江国潮 | Embrocation medicine for treating acute scrotum eczema and its preparation |
| CN101732462A (en) * | 2009-11-11 | 2010-06-16 | 宋爱民 | Chinese medicinal preparation for treating herpes zoster |
Non-Patent Citations (4)
| Title |
|---|
| 《新中医》 19961231 石秀兰 中药三黄洗剂在皮肤科的应用 105 1 , 第1期 * |
| 《青海医药杂志》 19950820 黄红英，王玉香 三黄洗剂的制备工艺及临床应用 16 1 , 第8期 * |
| 张东霞,1: "中医辨证治疗寻常痤疮临床观察", 《中国民族民间医药》 * |
| 肖红丽等,1: "陈汉章教授论中医止痒法", 《云南中医中药杂志》 * |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102784223A (en) * | 2012-07-23 | 2012-11-21 | 杭州市中医院 | Application of three-medicine ointment in preparation of drugs used for preventing and curing phlebitis |
| CN102908411A (en) * | 2012-11-21 | 2013-02-06 | 安文娟 | Ointment for treating acne |
| CN104523529A (en) * | 2015-01-08 | 2015-04-22 | 江苏省中医院 | Traditional Chinese medicine wet tissue for skin decontamination, preparation method thereof and traditional Chinese medicine composition |
| CN105055869A (en) * | 2015-07-21 | 2015-11-18 | 徐以燕 | Traditional Chinese medicinal external liniment and nursing method for treating rosacea with syndrome of heat-toxin exuberance |
| CN108378991A (en) * | 2018-05-07 | 2018-08-10 | 浙江卫星新材料科技有限公司 | Paper diaper containing kuh-seng |
| CN109646612A (en) * | 2019-02-28 | 2019-04-19 | 嘉兴市中医医院 | A kind of removing dampness to stop itchin mixture and preparation method thereof |
| CN109646612B (en) * | 2019-02-28 | 2021-06-08 | 嘉兴市中医医院 | Dampness-eliminating and itching-relieving mixture and preparation method thereof |
| CN110755508A (en) * | 2019-12-25 | 2020-02-07 | 长春雷允上药业有限公司 | Traditional Chinese medicine composition for relieving swelling and itching and preparation method thereof |
| CN110755508B (en) * | 2019-12-25 | 2021-11-26 | 长春雷允上药业有限公司 | Traditional Chinese medicine composition for relieving swelling and itching and preparation method thereof |
| CN114452318A (en) * | 2022-02-22 | 2022-05-10 | 威高(北京)医疗科技有限公司 | Anti-inflammatory traditional Chinese medicine composition for sanitary products and preparation method and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102258609B (en) | 2013-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102258609B (en) | Sanhuang antipruritic liniment and its preparation method | |
| CN102793785B (en) | Chinese rhubarb-baical skullcap root-amur corktree bark itching-relieving liniment and preparation method thereof | |
| CN100493594C (en) | Plaster for treating cholecystitis, cholangitis and bile gastritis | |
| CN101612278B (en) | Medicine for external application for treating pyogenic type contaminated wounds | |
| CN102343006A (en) | Ointment for treating burns and scalds, and preparation method thereof | |
| CN101856479B (en) | Chinese medicament for treating psoriasis vulgaris and preparation method thereof | |
| CN101390998A (en) | External medicine for treating osteomyelitis | |
| CN100522215C (en) | Traditional Chinese medicine composition for treating traumatic injury and bone fracture | |
| CN102755608B (en) | External application medicine for treating bronchitis | |
| CN102319271B (en) | Bedsore nursing powder | |
| CN102488774B (en) | Chinese medicinal powder for treating canker sore and preparation method thereof | |
| CN102000093A (en) | External ointment for treating impetigo | |
| CN1186068C (en) | Externally applied Chinese medicine with functions of diminishing inflammation, promoting granulation, stopping itch and stopping pain and its prepn process | |
| CN105434545A (en) | Preparation and application of drug percutaneous absorbent | |
| CN105560363A (en) | Traditional Chinese medicine external ointment for treating psoriasis and preparation method of traditional Chinese medicine external ointment | |
| CN1136857C (en) | Traditional Chinese medicine external preparation for curing piles | |
| CN1247204C (en) | Medicine for treating beri-beri | |
| CN103070950B (en) | External used Chinese medicine preparation for treating herpes zoster | |
| CN101019998A (en) | Medicine for treating anorectal diseases | |
| CN101002821B (en) | Ointment for treating herpes | |
| CN1439408A (en) | External used shengji paste | |
| CN100450516C (en) | Bone-setting Chinese medicinal capsule for treating bone fracture | |
| CN101884753A (en) | Medicament for treating empyrosis | |
| CN104510911A (en) | Drug composition for treating non-infectious inflammatory dermatosis and preparation method of drug composition | |
| CN112439006A (en) | Traditional Chinese medicine composition and tincture for treating intractable neurodermatitis and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130410 Termination date: 20140719 |
|
| EXPY | Termination of patent right or utility model |